United States, South Carolina — Rock Hill, South Carolina

United States, South Carolina is a clinical research site located in Rock Hill, South Carolina, United States 29732.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

United States, South Carolina has participated in 1 clinical trials.

Therapeutic areas: Crohn's Disease.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rock Hill

Browse all research sites in South Carolina · View every site in Rock Hill

• Winthrop University
• Levine Cancer Institute-Rock Hill
• Clinical Research of Rock Hill
• Research Site
• GSK Investigational Site
• Carolina Blood and Cancer Care Associates PA
• Rock Hill Radiation Therapy Center
• Carolina Blood and Cancer Care Associates
• Carolina Blood and Cancer Care
• OnSite Clinical Solutions
• Pearl Investigative Site
• Carolina Cardiology Associates

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for United States, South Carolina?

United States, South Carolina has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has United States, South Carolina conducted?

United States, South Carolina has 1 clinical trials on record. Their work covers Crohn's Disease.

Is United States, South Carolina accredited by Crixeo Clinical Trials?

United States, South Carolina has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about United States, South Carolina?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.